On Tuesday, Opus Genetics Inc (NASDAQ: IRD) was 4.37% up from the session before settling in for the closing price of $2.29. A 52-week range for IRD has been $0.65 – $2.37.
Healthcare Sector giant saw their annual sales surged by 24.32% over the last five years. When this article was written, the company’s average yearly earnings per share was at 68.70%. With a float of $47.75 million, this company’s outstanding shares have now reached $64.54 million.
Opus Genetics Inc (IRD) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Opus Genetics Inc stocks. The insider ownership of Opus Genetics Inc is 30.76%, while institutional ownership is 22.29%. The most recent insider transaction that took place on Dec 26 ’24, was worth 97,600. In this transaction Chief Executive Officer of this company bought 100,000 shares at a rate of $0.98, taking the stock ownership to the 599,150 shares.
Opus Genetics Inc (IRD) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.23 earnings per share (EPS) during the time that was better than consensus figure (set at -0.34) by 0.11. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 68.70% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 42.72% during the next five years compared to 24.32% growth over the previous five years of trading.
Opus Genetics Inc (NASDAQ: IRD) Trading Performance Indicators
You can see what Opus Genetics Inc (IRD) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.23. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 11.27.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.72, a number that is poised to hit -0.11 in the next quarter and is forecasted to reach -0.38 in one year’s time.
Technical Analysis of Opus Genetics Inc (IRD)
Analysing the last 5-days average volume posted by the [Opus Genetics Inc, IRD], we can find that recorded value of 1.14 million was better than the volume posted last year of 0.52 million. As of the previous 9 days, the stock’s Stochastic %D was 89.87%.
During the past 100 days, Opus Genetics Inc’s (IRD) raw stochastic average was set at 93.75%, which indicates a significant increase from 86.76% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.13 in the past 14 days, which was higher than the 0.12 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.00, while its 200-day Moving Average is $1.30. Now, the first resistance to watch is $2.49. This is followed by the second major resistance level at $2.59. The third major resistance level sits at $2.70. If the price goes on to break the first support level at $2.28, it is likely to go to the next support level at $2.17. Should the price break the second support level, the third support level stands at $2.07.
Opus Genetics Inc (NASDAQ: IRD) Key Stats
There are 68,964K outstanding shares of the company, which has a market capitalization of 164.83 million. As of now, sales total 10,990 K while income totals -57,530 K. Its latest quarter income was 3,080 K while its last quarter net income were -17,450 K.
